Next Article in Journal
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Next Article in Special Issue
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
Previous Article in Journal
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component
Previous Article in Special Issue
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
 
 
Review

Article Versions Notes

Cancers 2022, 14(24), 6245; https://doi.org/10.3390/cancers14246245
Action Date Notes Link
article pdf uploaded. 18 December 2022 15:42 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6245/pdf-vor
article xml file uploaded 21 December 2022 12:40 CET Original file -
article xml uploaded. 21 December 2022 12:40 CET Update https://www.mdpi.com/2072-6694/14/24/6245/xml
article pdf uploaded. 21 December 2022 12:40 CET Updated version of record https://www.mdpi.com/2072-6694/14/24/6245/pdf
article html file updated 21 December 2022 12:41 CET Original file -
article html file updated 1 March 2023 04:54 CET Update -
article html file updated 4 March 2023 22:41 CET Update -
article html file updated 3 September 2025 16:32 CEST Update https://www.mdpi.com/2072-6694/14/24/6245/html
Back to TopTop